The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank
Open Access
Abstract
No abstract availableAll Related Versions
Funding Information
- National Institute for Health and Care Research (RP-2017-08-ST2-014)
- National Institute for Health and Care Research (16/NW/0274)
- Wellcome Trust (WT202849/Z/16/Z)
- British Lung Foundation
- NIHR Leicester Biomedical Research Centre (77050)
- Health Foundation
- Medical Research Council (MR/N013913/1)
- Bayer
- GlaxoSmithKline
This publication has 11 references indexed in Scilit:
- Multi-ancestry genome-wide association study improves resolution of genes, pathways and pleiotropy for lung function and chronic obstructive pulmonary diseasemedRxiv, 2022
- Leveraging global multi-ancestry meta-analysis in the study of Idiopathic Pulmonary Fibrosis geneticsmedRxiv, 2021
- Tobacco Smoking and Risk for Pulmonary FibrosisChest, 2021
- Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosisCommunications Biology, 2021
- Activation of mitochondrial TUFM ameliorates metabolic dysregulation through coordinating autophagy inductionCommunications Biology, 2021
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary FibrosisMedicine, 2015
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old AgePLOS Medicine, 2015
- A CommonMUC5BPromoter Polymorphism and Pulmonary FibrosisNew England Journal of Medicine, 2011
- International statistical classification of diseases and related health problems. Tenth revision.1988